{"id":"W4387296889","doi":"10.1111/ajco.14030","title":"Re‐re‐biopsy? How much tumor is enough in the era of precision oncology?","year":2023,"lang":"en","type":"editorial","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Liquid biopsy; Erlotinib; Afatinib; Medicine; Precision medicine; Gefitinib; Cancer research; Lung cancer; Personalized medicine; Epidermal growth factor receptor; Targeted therapy; Oncology; Mutation; Biopsy; ROS1; Internal medicine; Cancer; Gene; Pathology; Bioinformatics; Adenocarcinoma; Biology; Genetics","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01707486,0.0007468947,0.002500482,0.001496291,0.001561521,0.005786553,0.002126172,0.005484461,0.006956239],"category_scores_gemma":[0.04557313,0.0005796327,0.001044659,0.0009809779,0.006403202,0.01668345,0.001968039,0.009310625,0.005256646],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003129852,"about_ca_system_score_gemma":0.002608069,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002788766,"about_ca_topic_score_gemma":0.005096894,"domain_scores_codex":[0.9945357,0.002509891,0.000525528,0.0007302667,0.001345198,0.0003534506],"domain_scores_gemma":[0.9677984,0.0183861,0.002253773,0.002160824,0.006711921,0.002689015],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007241876,0.00009637513,0.008836288,0.003393206,0.0002857602,0.001684252,0.0008481445,0.0005993752,0.002566139,0.01849129,0.2484144,0.7140606],"study_design_scores_gemma":[0.0001226287,0.0004614224,0.007140547,0.01087632,0.0004986682,0.01785102,0.005228197,0.001670138,0.002821874,0.116485,0.8365523,0.0002918615],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"editorial","genre_scores_codex":[0.007184,0.4340312,0.01682371,0.5133587,0.0197954,0.00008214822,0.000318399,0.0004092186,0.007997229],"genre_scores_gemma":[0.1628226,0.40882,0.03656647,0.3113424,0.06859366,0.0002691311,0.000900241,0.0009013362,0.009784169],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.01707486,"threshold_uncertainty_score":0.09030151,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07119682710064731,"score_gpt":0.4902238850880357,"score_spread":0.4190270579873884,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}